BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2946895)

  • 21. The cardiocirculatory and metabolic effects of endotoxin challenge after canine resuscitated hemorrhagic shock.
    Horton J
    J Trauma; 1989 Feb; 29(2):195-202. PubMed ID: 2563778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic effects of antagonists of the vasoconstrictor action of vasopressin in conscious dogs.
    Liard JF; Spadone JC
    J Cardiovasc Pharmacol; 1984; 6(4):713-9. PubMed ID: 6206331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular improvement due to RA642, a pyrimido-pyrimidine derivative, in canine endotoxin shock.
    Koyama S
    Circ Shock; 1984; 13(4):341-51. PubMed ID: 6478548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When does the heart fail during shock?
    Raymond RM
    Circ Shock; 1990 Jan; 30(1):27-41. PubMed ID: 2137382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of naloxone on endotoxin-induced changes in ponies.
    Moore AB; Roesel OF; Fessler JF; Bottoms GD
    Am J Vet Res; 1983 Jan; 44(1):103-9. PubMed ID: 6337534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.
    Natanson C; Eichenholz PW; Danner RL; Eichacker PQ; Hoffman WD; Kuo GC; Banks SM; MacVittie TJ; Parrillo JE
    J Exp Med; 1989 Mar; 169(3):823-32. PubMed ID: 2647895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endotoxin shock: prevented by naloxone in intact but not hypophysectomized rats.
    Davis SD; McDonald WJ; Kendall JW; Potter DM
    Proc Soc Exp Biol Med; 1984 Mar; 175(3):380-5. PubMed ID: 6320213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendocrine and cardiovascular responses to high-dose corticosteroid therapy in canine endotoxin shock.
    Watson JD; Varley JG; Tomlin SJ; Medbak S; Perry L; Bouloux PM; Rees LH; Besser GM; Hinds CJ
    Res Exp Med (Berl); 1988; 188(5):329-39. PubMed ID: 3227157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of endogenous opioids in congestive heart failure: effects of nalmefene on systemic and regional hemodynamics in dogs.
    Liang CS; Imai N; Stone CK; Woolf PD; Kawashima S; Tuttle RR
    Circulation; 1987 Feb; 75(2):443-51. PubMed ID: 3026683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endotoxic shock elicits greater endorphin secretion than hemorrhage.
    Hamilton AJ; Carr DB; LaRovere JM; Black PM
    Circ Shock; 1986; 19(1):47-54. PubMed ID: 2941182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of hemorrhagic shock and endotoxin shock on plasma levels of beta-endorphin and beta-lipotropin.
    Oyama T; Yao M; Ishihara H; Kudo T; Kudo M; Matsuki A
    Prog Clin Biol Res; 1983; 111():185-96. PubMed ID: 6306679
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of temperature on naloxone treatment in canine hemorrhagic shock.
    Horton JW; Tuggle DW; Kiser RS
    Circ Shock; 1984; 14(4):251-65. PubMed ID: 6096039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased myocardial contractility during endotoxin shock in dogs.
    Kober PM; Thomas JX; Raymond RM
    Am J Physiol; 1985 Oct; 249(4 Pt 2):H715-22. PubMed ID: 4051010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular effects associated with antidiuretic activity of vasopressin after blockade of its vasoconstrictor action in dehydrated dogs.
    Liard JF
    Circ Res; 1986 May; 58(5):631-40. PubMed ID: 3754791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for a role of opioid peptides in the release of arginine vasopressin in the conscious rat.
    Ishikawa S; Schrier RW
    J Clin Invest; 1982 Mar; 69(3):666-72. PubMed ID: 6174549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canine peripheral vascular response to endotoxin shock at a constant cardiac output.
    Abel FL; Beck RR
    Circ Shock; 1988 Aug; 25(4):267-74. PubMed ID: 3048772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of angiotensin I and glucagon in canine endotoxin shock: effect of converting enzyme inhibitor and prior immunization.
    Manson NH; Hess ML
    Circ Shock; 1984; 12(3):177-89. PubMed ID: 6325034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of a V1-vasopressin antagonist on ACTH release following vasopressin infusion or insulin-induced hypoglycemia in normal men.
    Hader O; Bähr V; Hensen J; Hofbauer KG; Oelkers WK
    Acta Endocrinol (Copenh); 1990 Dec; 123(6):622-8. PubMed ID: 2178298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naloxone alters organ perfusion during endotoxin shock in conscious rats.
    Law WR; Ferguson JL
    Am J Physiol; 1988 Nov; 255(5 Pt 2):H1106-13. PubMed ID: 3189572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antagonism of vasopressin-induced coronary artery constriction by the vasopressin antagonist d(CH2)5Tyr(Me)-AVP.
    Kopia GA; Valocik RE
    J Cardiovasc Pharmacol; 1985; 7(5):958-63. PubMed ID: 2413308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.